Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by recurring abscesses, nodules, and fistulas predominantly in the groin and axillae. The association between HS and Crohn's disease (CD) has been well documented. Tumor necrosis factor (TNF) inhibitors have sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Harvin, Glenn, Kasarala, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929363/
https://www.ncbi.nlm.nih.gov/pubmed/27403108
http://dx.doi.org/10.1159/000444442
_version_ 1782440594163892224
author Harvin, Glenn
Kasarala, George
author_facet Harvin, Glenn
Kasarala, George
author_sort Harvin, Glenn
collection PubMed
description Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by recurring abscesses, nodules, and fistulas predominantly in the groin and axillae. The association between HS and Crohn's disease (CD) has been well documented. Tumor necrosis factor (TNF) inhibitors have shown to be effective in treating both HS and CD. We report 2 patients who developed HS while on TNF inhibitor treatment for CD.
format Online
Article
Text
id pubmed-4929363
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-49293632016-07-11 Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab Harvin, Glenn Kasarala, George Case Rep Gastroenterol Case Report Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by recurring abscesses, nodules, and fistulas predominantly in the groin and axillae. The association between HS and Crohn's disease (CD) has been well documented. Tumor necrosis factor (TNF) inhibitors have shown to be effective in treating both HS and CD. We report 2 patients who developed HS while on TNF inhibitor treatment for CD. S. Karger AG 2016-05-19 /pmc/articles/PMC4929363/ /pubmed/27403108 http://dx.doi.org/10.1159/000444442 Text en Copyright © 2016 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Harvin, Glenn
Kasarala, George
Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab
title Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab
title_full Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab
title_fullStr Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab
title_full_unstemmed Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab
title_short Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab
title_sort two cases of paradoxical hidradenitis suppurativa while on adalimumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929363/
https://www.ncbi.nlm.nih.gov/pubmed/27403108
http://dx.doi.org/10.1159/000444442
work_keys_str_mv AT harvinglenn twocasesofparadoxicalhidradenitissuppurativawhileonadalimumab
AT kasaralageorge twocasesofparadoxicalhidradenitissuppurativawhileonadalimumab

Ejemplares similares